Please visit answersincme.com/GZT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses the latest data in systemic treatments for children with moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Recognize the rationale for treatment intensification with novel systemic agents when managing children with moderate-to-severe atopic dermatitis (AD); Review the latest clinical data informing the current and future use of novel systemic agents in children with moderate-to-severe AD; and Identify opportunities for shared decision-making to improve the care of children with moderate-to-severe AD.
View all episodes
